Standout Papers

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inad... 2004 2026 2011 2018 815
  1. Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE (2004)
    Marc Humbert, Richard Beasley et al. Allergy

Immediate Impact

3 from Science/Nature 73 standout
Sub-graph 1 of 20

Citing Papers

GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation
2024 Standout
1 intermediate paper

Works of Sância Ramos being referenced

High-grade urothelial carcinoma in a kidney transplant recipient after JC virus nephropathy: The first evidence of JC virus as a potential oncovirus in bladder cancer
2019
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
2004 Standout

Author Peers

Author Last Decade Papers Cites
Sância Ramos 101 169 90 787 635 53 1.2k
Pamela A. Frischmeyer‐Guerrerio 119 392 44 501 336 56 1.7k
Nicole Graf 18 134 38 470 335 38 1.5k
Alastair Hansen 33 235 107 253 168 51 1.3k
Felix Chua 102 148 206 263 958 52 1.4k
Martin Laudien 15 152 88 308 641 53 993
Manali Mukherjee 6 288 48 860 531 56 1.2k
Monica G. Lawrence 11 98 89 387 195 49 1.0k
Carina Malmhäll 26 171 95 450 204 48 1.6k
Jeremy D. Wolfe 58 47 98 182 215 79 1.4k
Claudia Sengler 10 114 57 326 221 43 1.2k

All Works

Loading papers...

Rankless by CCL
2026